In 2023, the pancreas malignant neoplasms mortality rate in Brazil was approximately 6.4 deaths per hundred thousand men. Forecasted data for 2024 to 2028 suggests a steady increase, reaching 7.3 deaths by 2028. The year-on-year variations indicate a consistent upward trend: a 3.03% increase in 2025, 1.47% in 2026, 2.90% in 2027, and 2.82% in 2028. The compound annual growth rate (CAGR) over the five-year period is approximately 2.72%.
Future trends to watch for include the potential impact of advancements in medical treatments, early detection methods, lifestyle changes, and public health initiatives aimed at reducing mortality rates. Monitoring these factors will be essential for understanding and curbing the increase in mortality from pancreas malignant neoplasms in Brazil.
